Cargando…

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer

Long noncoding RNAs (lncRNAs) have multiple functions in the cancer immunity response and the tumor microenvironment. To investigate the immune-related lncRNA (IRlncRNA) signature for predicting prognosis and immunotherapeutic response in bladder cancer (BLCA), we extracted BLCA data from The Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yucai, Zhang, Lei, He, Shiming, Guan, Bao, He, Anbang, Yang, Kunlin, Gong, Yanqing, Li, Xuesong, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746369/ https://www.ncbi.nlm.nih.gov/pubmed/33221763 http://dx.doi.org/10.18632/aging.104115

Ejemplares similares

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma
por: Wu, Yucai, et al.
Publicado: (2021)

ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers
por: He, Anbang, et al.
Publicado: (2018)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2023)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer
por: Kong, Xiaoyu, et al.
Publicado: (2023)

High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center
por: Li, Yifan, et al.
Publicado: (2019)

TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
por: Chen, Zhicong, et al.
Publicado: (2019)

Prognostic value of long non-coding RNA signatures in bladder cancer
por: He, Anbang, et al.
Publicado: (2019)

Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2
por: Zhan, Yonghao, et al.
Publicado: (2017)

Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2018)

Correction: Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2023)

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2020)

Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2023)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome
por: Guan, Bao, et al.
Publicado: (2022)

Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma
por: Zhang, Jianye, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
por: Chen, Jia, et al.
Publicado: (2022)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
por: Zhang, Cuijian, et al.
Publicado: (2021)

AB169. CCDC34 is up-regulated in bladder cancer and its silencing suppresses bladder cancer cell proliferation and migration
por: Gong, Yanqing, et al.
Publicado: (2015)

Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
por: Peng, Ding, et al.
Publicado: (2018)

Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
por: Guan, Bao, et al.
Publicado: (2018)

Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis
por: Li, Yifan, et al.
Publicado: (2018)

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
por: Xie, Haibiao, et al.
Publicado: (2017)

An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
por: Hou, Jian, et al.
Publicado: (2022)

Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer
por: Li, Canxuan, et al.
Publicado: (2023)

Upregulation of ATP Binding Cassette Subfamily C Member 5 facilitates Prostate Cancer progression and Enzalutamide resistance via the CDK1-mediated AR Ser81 Phosphorylation Pathway
por: Ji, Guangjie, et al.
Publicado: (2021)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma
por: Bao, Zhengqing, et al.
Publicado: (2019)

Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells
por: Chen, Zhicong, et al.
Publicado: (2016)

Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Terminal augmented ureteroplasty with bladder onlay flap technique for recurrent distal ureteral stricture after ureteroneocystostomy: an initial case series
por: Wu, Yucai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l265834asigj6m67gi35im77jb